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Abstract
Background: Ischemic pre- and postconditioning protects the liver against ischemia/reperfusion injuries. The aim
of the present study was to examine how ischemic pre- and postconditioning affects gene expression of hypoxia
inducible factor 1a (HIF-1a), vascular endothelial growth factor A (VEGF-A) and transforming growth factor b (TGF-
b) in liver tissue.
Methods: 28 rats were randomized into five groups: control; ischemia/reperfusion; ischemic preconditioning (IPC);
ischemic postconditioning (IPO); combined IPC and IPO. IPC consisted of 10 min of ischemia and 10 min of
reperfusion. IPO consisted of three cycles of 30 sec. reperfusion and 30 sec. of ischemia.
Results: HIF-1a mRNA expression was significantly increased after liver ischemia compared to controls (p = 0.010).
HIF-1a mRNA expression was significantly lower in groups subjected to IPC or combined IPC and IPO when
compared to the ischemia/reperfusion group (p = 0.002). VEGF-A mRNA expression increased in the ischemia/
reperfusion or combined IPC and IPO groups when compared to the control group (p < 0.05).
Conclusion: Ischemic conditioning seems to prevent HIF-1a mRNA induction in the rat liver after ischemia and
reperfusion. This suggests that the protective effects of ischemic conditioning do not involve the HIF-1 system. On
the other hand, the magnitude of the HIF-1a response might be a marker for the degree of I/R injuries after liver
ischemia. Further studies are needed to clarify this issue.
Background
Colorectal cancer is a leading form of cancer in the
Western world. Approximately 50% of patients with this
disease have, or will eventually develop, liver metastases.
Surgical removal of those metastases remains the treat-
ment of choice, with a five year survival rate of 37%-
58% after resection [1-3]. Major hemorrhage and blood
transfusion during liver resection is related to an
increase in morbidity and mortality [4-6]. Vascular
clamping is a frequently used method for reducing
blood loss [7]. Several studies have shown that the nor-
mal livers tolerate periods of continuous warm ischemia
up to 90 min and intermittent warm ischemia up to 120
min [8-10].
However, ischemia/reperfusion (I/R) injury of the liver
is an unfortunate side effect of this method, ranging
from slightly elevated liver enzymes to acute liver failure
[11]. Ischemic pre- or postconditioning (IPC or IPO),
defined as brief periods of ischemia and reperfusion
before or after sustained ischemia, have proven to
increase the ability of organs to tolerate I/R injury
[12-16]. The precise mechanisms responsible for the
hepatoprotection from ischemic injuries are only par-
tially known. Focus has been on a system of hypoxia
inducible factors (HIF), where especially HIF-1 appears
to have a major role in cellular adaptation to hypoxia.
HIF-1 mediates essential homeostatic responses to cellu-
lar hypoxia by up-regulating gene transcription, via spe-
cific DNA motif called hypoxia response elements, and
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consisting of an a and b-subunit. The b-subunit is
expressed ubiquitously in most cells, whereas expression
of the a-subunit is controlled by cellular oxygen tension.
Under normal conditions the HIF-1a protein is
degraded via an oxygen dependent system. By contrast,
hypoxia inactivates the degradation causing stabilization
of the HIF-1a protein, which then translocate to the
nucleus and forms dimers with the b-subunit [17]. The
active form of HIF-1 transactivates other genes as vascu-
lar endothelial growth factor (VEGF) and transforming
growth factor b1( T G F - b1) [18,19]. VEGF is an impor-
tant growth factor involved in angiogenesis. It is a mul-
tifunctional protein, with several effects on endothelial
cells to promote the formation of new vessels. Further-
more, it stimulates the production of hepatocyte growth
factor (HGF), which is regarded as an initiator of liver
regeneration [20]. TGF-b1 is a member of the superfam-
ily of cytokines. In the liver, TGF-b1 has anti-inflamma-
tory properties and stimulates cell proliferation as well
as differentiation [20].
Besides I/R injuries, another possible drawback of liver
ischemia in cancer surgery could be growth stimulation
of micrometastases. Several studies indicate that the out-
growth of micrometastases is stimulated by I/R injuries
during hepatic resections [21-23]. Outgrowth of these
micro metastases may at least in part, be stimulated by
an increased HIF-1a stabilization [22]. As mentioned
above, HIF-1a activates other genes such as VEGF and
TGF-b. Especially VEGF is an important growth factor
involved in angiogenesis [24-26]. In this sense a stimula-
tion of HIF-1a, via liver ischemia, could be a double-
edged sword; i.e., it protects the liver against I/R inju-
ries, but a side effect could be the growth stimulation of
micrometastases through angiogenesis.
T h ea i mo ft h ep r e s e n ts t u d yw a st oe x a m i n eh o w
ischemia, with or without IPC and IPO, affects the
expression of HIF-1a and the target genes VEGF and
TGF-b1, in rodent liver.
Methods
The surgical and experimental protocols were approved
by the Danish Animal Research Committee, Copenha-
gen, Denmark according to license number 2007/561-
1311 and followed the G u i d ef o rt h eC a r ea n dU s eo f
Laboratory Animals published by the National Institute
of Health. Twenty-eight adult male Wistar rats weighing
300-350 g (M&B Taconic, Eiby, Denmark) were used for
the experiment. Animals were housed in standard ani-
mal laboratories with a temperature maintained at 23°C
and an artificial 12-hour light-dark cycle, with food and
water ad libitum, until the time of the experiment. The
rats were randomly divided into five groups as follows:
sham operated control (CG) (n = 4); pure ischemia and
reperfusion (IRI) (n=6 ); IPC (n=6 ); IPO (n=6 ); and
IPC+IPO (n=6 ) (Figure 1). All animals were anaesthe-
tized with 0.75 ml/kg Hypnorm s.c. (Fentanyl/Fluani-
sone, Jansen Pharma, Birkerød, Denmark) and 4 mg/kg
M i d a z o l a ms . c .( D o r m i c u m ,L aR o c h e ,B a s e l ,S w i t z e r -
land) and placed on a heated pad. A midline laparotomy
was performed and total hepatic ischemia was accom-
plished using a microvascular clamp placed on the hepa-
toduodenal ligament, i.e., performing the Pringle
maneuver. Reflow was initiated by removal of the clamp.
Discoloration of the liver was used as a positive marker
for hepatic ischemia. Reperfusion was ascertained by the
return of the normal brown/reddish color of the liver.
The experimental protocol was performed as described
in Figure 1. At the end of each experiment after 30 min
of reperfusion, a biopsy was taken from the right liver
lobe, immediately frozen in liquid nitrogen and stored at
-80°C for further analysis. Blood samples were collected
from the common iliac artery in tubes for measurement
of alanine aminotransferase (ALAT), alkaline phosphates
and bilirubin, and analyzed immediately hereafter. All
rats were subsequently killed with an overdose of
pentobarbital.
Quantitative Real-Time PCR (RT-PCR)
After homogenization of liver tissue by the use of a
MM301 Mixer Mill (Retsch, Haan, Germany), total cel-
lular RNA was extracted from the liver tissue using a
6100 Nucleic Acid PrepStation (Applied Biosystems,
Foster City, CA, USA). The quality of rRNA was esti-
mated by agarose gel electrophoresis by the appearance
of two distinct bands visible by fluorescence of ethide
Figure 1 Experimental protocol of the five groups.B l a c ka r e a s
represent periods of hepatic ischemia; white areas represent periods
of normal hepatic blood perfusion. Liver biopsies were collected at
the end of each experiment. CG, Control group. IRI, 30 min of
ischemia. IPC, ischemic preconditioning + 30 min of ischemia. IPO,
30 min ischemia + ischemic postconditioning. IPC+IPO, ischemic
preconditioning + 30 min of ischemia + ischemic postconditioning.
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RNA extracted were quantified by measuring the absor-
bance by spectrophotometry, at 260 nm. Reverse tran-
scription from RNA to DNA was performed with a
Multiscribe Reverse Transcriptase kit from Applied Bio-
system at 25°C for 10 min, at 48°C for 30 min and at
94°C for 29 sec. The PCR was performed in triplicates
of each sample in a volume of 25 μL in each well con-
taining RNA, TaqMan Universal PCR MasterMix and a
primer of the target, i.e., HIF-1a (Rn00577560_m1),
TGF-b (Rn00572010_m1) and VEGF-A (Rn4331348),
and a primer of the housekeeping gene, 18S (4319413),
all purchased from Applied Biosystems. Each RT-PCR
reaction ran at 50°C for 2 min, at 95°C for 10 min and
in 40 cycles changing between 95°C for 15 sec. and 60°C
for 1.30 min [27].
PCR Data analysis
Data was analyzed with the ABI Prism 7000 Sequence
Detector Software from Applied Biosystems. The output
of amplification was measured in the exponential phase
of the reaction as the threshold cycle/Ct-value, which is
defined as the cycle number at which amplification pro-
ducts are detected corresponding to the point where
fluorescent intensity exceeds the background fluorescent
intensity, which is 10 × the standard deviation of the
baseline. The average of triplicates from each sample
was used. The relative quantification of target gene was
calculated using the formula: (1/2)
Ct-target gene- Ct-house-
keeping gene, which is described in the Users Bulletin 2,
1997 from Perkin-Elmer (Perkin-Elmer Cetus, Norwalk,
CT, USA) [27].
Statistical analysis
Statistical analysis were performed by SPSS
® 11.0 pro-
grams (SPSS Inc., Chicago, Illinois, USA). All data is
expressed as mean ± SEM. Comparisons of data between
groups were performed by non-parametric Kruskal-
Wallis (ANOVA) test followed by the Mann-Whitney U-
test. A p value < 0.05 was considered significant.
Results
Liver parameters
Blood samples showed a significant increase in ALAT in
group IRI (334 ± 135 U/L), IPC (377 ± 104 U/L), IPO
(1177 ± 379 U/L) and IPC+IPO (710 ± 199 U/L) com-
pared to the control group (40 ± 2 U/L) (CG vs. IRI,
IPC, IPO, and IPC+IPO, p = 0.01). No significant differ-
ences were found in ALAT between groups IRI, IPC,
IPO and IPC+IPO. Alkaline phosphates and bilirubin
were comparable between groups (Figure 2).
HIF-1a expression
In the IRI group the expression of HIF-1a mRNA was
significantly increased after 30 min of reperfusion com-
pared to the control group (p ≤ 0.01). In the IPC group
HIF-1a mRNA expression was significantly lower than
the IRI group (p ≤ 0.01). In rats subjected to IPO there
was a tendency towards lower HIF-1a mRNA expres-
sion compared to the IRI group (p = 0.065). In the IPC
+IPO group HIF-1a mRNA expression was significantly
lower compared to the IRI group (IRI vs. IPC+IPO, p ≤
0.01). The HIF-1a mRNA levels were comparable
between group CG, IPC, IPO and IPC+IPO (Figure 3)
VEGF expression
As shown in Figure 4, VEGF mRNA expression was signif-
icantly increased in the IRI group compared to the control
group (p ≤ 0.01). When applying IPC+IPO VEGF mRNA
expression was also increased compared to the control
group (p ≤ 0.038). No significant differences were observed
between groups IPC, IPO and the control group (IPC vs.
CG, p ≤ 0.067) and (IPO vs. CG, p ≤ 0.067).
TGF-b1 expression
No differences in TGF-b1 mRNA expression were
observed between the five groups (Figure 5).
Discussion
As expected HIF-1a mRNA expression was increased
significantly in rats subjected to 30 minutes of warm
Figure 2 Blood samples including ALAT (A), alkaline phosphatase (AP) (B) and bilirubin (C) levels. Samples 30 min after reperfusion in CG,
Control group. IRI, 30 min of ischemia. IPC, ischemic preconditioning + 30 min of ischemia. IPO, 30 min ischemia + ischemic postconditioning.
IPC+IPO, ischemic preconditioning + 30 min of ischemia + ischemic postconditioning. * indicates p ≤ 0.01 compared to the control group.
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to the control group. The main finding of this study was
an absent of HIF-1a induction in IPC or IPC+IPO trea-
ted animals. In both of these groups, the expression
levels were similar to that of CG. In the IPO group the
same tendency towards an absent induction of HIF-1a
was observed although not significant. VEGF mRNA
expression increased significantly when applying 30 min
of ischemia without ischemic conditioning compared to
sham operated controls. IPC+IPO also showed increased
VEGF mRNA expression compared to sham operated
controls, whereas neither ischemia nor ischemic condi-
tioning affected hepatic TGF-b expression.
The cytoprotective effects of IPC, defined as brief peri-
ods of ischemia and reperfusion prior to prolonged
ischemia, on I/R injuries to the liver have become indis-
putable with an increasing number of studies supporting
this fact [12-14]. The IPC protocol used in this study
has previously been shown to induce hepatoprotection
against I/R injuries. We choose circulating ALAT as
marker of hepacellular injuries, as this parameter is well
established and known to correlate to the degree of
injury [28-30]. However, we were unable to see any
hepatoprotective effects as assessed by changes in liver
parameters. In previous studies with the same IPC pro-
tocol, longer periods of ischemia and longer reperfusion
periods were utilized [12,14,31]. This might explain why
we were not able to demonstrate protective effects of
IPC and IPO as judged by liver parameters, i.e., the
duration of ischemia was too short. Furthermore, 30
min of reperfusion might be too short follow up to
demonstrate the full extent of the I/R injuries. The cyto-
protective effect of IPO, defined as brief periods of
ischemia and reperfusion after liver ischemia, is less well
established [15,16]. In the present study, we could not
demonstrate any hepatoprotective effects of IPO
assessed by liver parameters, and we speculate that the
explanation may be the same as above. We choose the
Figure 3 Expression of HIF-1a mRNA. Expression after 30 min of
reperfusion. CG, Control group. IRI, 30 min of ischemia. IPC, IPC +
30 min of ischemia. IPO, 30 min ischemia + IPO. IPC+IPO, IPC + 30
min of ischemia + IPO. * indicates p ≤ 0.01 compared to group IRI.
¤ indicates p = 0.065 compared to group IRI.
Figure 4 Expression of VEGF mRNA. Expression after 30 min of
reperfusion. CG, Control group. IRI, 30 min of ischemia. IPC, IPC +
30 min of ischemia. IPO, 30 min ischemia + IPO. IPC+IPO, IPC + 30
min of ischemia + IPO. *indicates p ≤ 0.01 compared to group CG.
**indicates p ≤ 0.038 compared to group CG.
Figure 5 Expression of TGF-b1m R N A . Expression after 30 min of
reperfusion. CG, Control group. IRI, 30 min of ischemia. IPC, IPC +
30 min of ischemia. IPO, 30 min ischemia + IPO. IPC+IPO, IPC + 30
min of ischemia + IPO.
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because we wanted to create a setting relevant for nor-
mal clinics. Even though longer periods of liver ischemia
have been safely applied, most surgeons would be reluc-
tant to induce more than 30 minutes of ischemia on the
liver.
The mechanisms responsible for the protective effects
of IPC and IPO are only partially understood. In the
present study, IPC resulted in a significantly lower
expression of HIF-1a mRNA compared with rats sub-
jected to liver ischemia without IPC. This leads us to
conclude that HIF-1a, in our model of modest I/R-inju-
ries, does not seem to be a mediator of the cyto-protec-
tive effects of IPC. In rats subjected to IPO there was a
tendency towards lower HIF-1a mRNA expression,
although not significant, when compared to the sheer
liver ischemia group. This indicates that HIF 1a is not
involved in the cytoprotective effects of IPO. In this
sense, the HIF-1a mRNA response could to be a marker
of the degree of I/R injury, i.e., the higher HIF-1a
mRNA response after ischemia, the more pronounced I/
R injuries. Further studies need to be performed to
address this issue, but it is first and foremost supported
in a study by Cursio et al., where they showed that the
expression of HIF-1 and the degree of apoptosis was
increased in rats subjected to 120 min of warm liver
ischemia compared to non-ischemia [32]. Another study
supporting the conclusion in the present paper is that
by Feinman et al. [33]. They used partially HIF-1 defi-
cient mice in a hemorrhagic shock model and concluded
that HIF-1 activation was necessary for ischemic gut
mucosal injury.
The expression of VEGF mRNA was regulated
upwards by the ischemic episodes in the group sub-
jected to sustained ischemia and in the IPC+IPO group.
A higher expression of VEGF in the group with liver
ischemia only, correlates with the elevated HIF-1a
expression in this group. TGF-b expression levels were
not affected in any of the groups. Both VEGF and TGF-
b are, as previously described, genes that are regulated
downstream of HIF-1a.H o w e v e r ,a st h i ss t u d yo n l y
focuses on the expression levels after 30 min of reperfu-
s i o n ,w ec a n n o tb es u r et h a tw ea r em e a s u r i n gt h ef u l l
effect of the changed HIF-1a levels. If we had followed
the expression levels over time, we might have seen a
more direct correlation, as already reported [34].
Conclusions
Ischemic conditioning seems to prevent HIF-1a mRNA
induction in the rat liver after ischemia and reperfusion.
This suggests that the protective effects of ischemic con-
ditioning do not involve the HIF-1 system. On the other
hand, the magnitude of the HIF-1a response might be a
marker for the degree of I/R injuries after liver ischemia.
Further studies need to be performed to elucidate this
matter.
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